news Groundbreaking data tool may uncover novel class of GPCRs 27 October 2021 | By Anna Begley (Drug Target Review) A new computer-aided tool maps allosteric sites in G protein-coupled receptors to search for allosteric drugs to treat a range of diseases.
news Researchers discover process viruses use to block antiviral immune response 16 February 2021 | By Victoria Rees (Drug Target Review) A team has revealed that viruses ‘hijack’ a molecular process in the cell, inhibiting the body’s response to viral infection.
news Researchers take a leap forward for new anti-inflammatory drugs 13 May 2019 | By Drug Target Review Treatments for chronic inflammatory diseases are one step closer as a new study discovers a way to stop inflammation in its tracks.
news Queen’s researchers breakthrough discovery in fight against bowel cancer 1 June 2017 | By Niamh Marriott (Drug Target Review) New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.
news Study shows potential of stem cell therapy to repair lung damage 28 March 2017 | By Niamh Marriott (Drug Target Review) A new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still at a pre-clinical stage, these findings have important potential implications for the future treatment of patients.
news Increased protein activity makes bowel cancer drug resistant 9 November 2016 | By Niamh Louise Marriott, Digital Content Producer Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the National Cancer Research...
news CV drug Darapladib shows potential in diabetic macular oedema 14 June 2016 | By Victoria White, Digital Content Producer The discovery demonstrates that Darapladib has potential to provide protection against vision loss in a much wider group of patients with diabetes...
news DNA from 20,000 people to help discover new treatments for diabetic kidney disease 3 June 2016 | By Victoria White, Digital Content Producer Researchers are to examine DNA samples from 20,000 people with diabetes to help identify the genetic factors in diabetic kidney disease...
news New €2.25m international project to tackle diabetes-related blindness 28 April 2016 | By Victoria White, Digital Content Producer A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
article Advancing FLIP inhibitors for the treatment of NSCLC 26 April 2016 | By Victoria White, Drug Target Review In an exclusive interview, Trevor Perrior, Research Director at Domainex, discusses the cell death regulatory protein FLIP and the potential of FLIP inhibitors as a treatment for NSCLC...
news Queen’s University Belfast and Domainex secure award to advance FLIP inhibitor 26 April 2016 | By Victoria White, Digital Content Producer Queen’s University Belfast and Domainex have secured an award to advance therapeutic candidate molecules into clinical evaluation for treatment of NSCLC...
